- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11:18 | Intellia's three-year HAE treatment data shows durability, Citizens JMP says | 1 | Investing.com | ||
| 11:18 | Citizens JMP reiterates Terns Pharmaceuticals stock rating on positive data | 1 | Investing.com | ||
| 11:18 | PolyPid stock price target lowered to $14 at JMP on warrant dilution | 2 | Investing.com | ||
| 11:18 | Sagimet stock holds steady as JMP reiterates $31 price target | 3 | Investing.com | ||
| 10:46 | NextCure and Simcere partner to develop SIM0505 for solid tumours | 1 | Pharmaceutical Technology | ||
| 10:30 | EILMELDUNG bei CureVac: Insider kaufen massenhaft Anteile - Sofortiges HANDELN erforderlich! | Hebelschein-Spekulant | |||
| 10:17 | HK-Based Herbal Stock Regencell Bioscience Soars 460x This Yr w/Mkt Cap Nearing USD30B in Absence of Any Rev. Recorded | 1 | AASTOCKS | ||
| 10:12 | Eli Lilly nears $1.3B deal for Verve Therapeutics - report | 13 | Seeking Alpha | ||
| 09:19 | XFRA BNE0: WIEDERAUFNAHME/RESUMPTION | 90 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 09:15 | Evotec Aktie: Wann kommt der große Ausbruch? | 389 | 4investors | Evotecs Aktien zeigt weiterhin ein charttechnisch wenig richtungsweisendes Bild und pendelt in einer seit Monaten anhaltenden übergeordneten Seitwärtsbewegung zwischen 5,06 Euro auf der Unterseite und... ► Artikel lesen | |
| 09:10 | Recce locks in $30M to boost commercialisation across ASEAN region | 2 | The Market Herald Australia | ||
| 09:06 | Cantargia Q1 2025 slides: CAN10 advances amid funding challenges | 2 | Investing.com | ||
| 09:02 | Alligator Bioscience: Alligator Receives Positive Scientific Advice from EMA on Phase 3 Trial of Mitazalimab | 135 | ACCESS Newswire | LUND, SE / ACCESS Newswire / June 17, 2025 / Alligator Bioscience (STO:ATORX) - Lund, Sweden, 17 June 2025 - Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company developing... ► Artikel lesen | |
| 08:55 | Another Executive Change at Leading Chinese Beauty Company Bloomage Biotech | 1 | Chaileedo | ||
| 08:37 | XFRA FA20,0RA0,4070: AUSSETZUNG/SUSPENSION | 166 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFORWARD AIR CORP.... ► Artikel lesen | |
| 08:30 | Alzinova AB: Alzinova selects Worldwide Clinical Trials as CRO partner for Phase 2 study of ALZ-101 | 16 | GlobeNewswire (Europe) | Alzinova AB (Nasdaq First North: ALZ) today announces a strategic collaboration with Worldwide Clinical Trials ("Worldwide"), a global leader in neuroscience studies, appointing them as the Clinical... ► Artikel lesen | |
| 08:09 | 4BASEBIO PLC: Holding(s) in Company | 13 | Cision News | ||
| 08:06 | 4basebio Plc - Holding(s) in Company | 88 | PR Newswire | 4basebio Plc - Holding(s) in Company
PR Newswire
LONDON, United Kingdom, June 17
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BMCLYF79... ► Artikel lesen | |
| 08:06 | 4basebio Plc - Holding(s) in Company | 114 | PR Newswire | 4basebio Plc - Holding(s) in Company
PR Newswire
LONDON, United Kingdom, June 17
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BMCLYF79... ► Artikel lesen | |
| 08:02 | Genflow Biosciences PLC Announces Corporate Update | 126 | ACCESS Newswire | Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF)... ► Artikel lesen |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| SAREPTA THERAPEUTICS | 24 | 1 | +2,07 % | Sarepta-Aktie crasht erneut: Weiterer Todesfall | Aktionäre der Biotech-Gesellschaft Sarepta Therapeutics müssen einen weiteren Rückschlag hinnehmen. Am Wochenende berichtete das Unternehmen und sein Pharma-Partner Roche über einen weiteren Todesfall... ► Artikel lesen | ||
| SUPERNUS | 11 | 5 | +0,72 % | Supernus To Acquire Sage Therapeutics; Strengthens Psychiatry Portfolio With ZURZUVAE Capsules CIV | WESTON (dpa-AFX) - Supernus Pharmaceuticals (SUPN) and Sage Therapeutics (SAGE) announced a definitive agreement for Supernus to acquire Sage through a tender offer for $8.50 per share in cash... ► Artikel lesen | ||
| SAGE THERAPEUTICS | 8 | 11 | -1,86 % | XFRA SG7: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSAGE THERAPEUTICS... ► Artikel lesen | ||
| 23ANDME | 7 | 8 | -18,16 % | Silver Scott Mines Inc: Silver Scott Health, Inc. Unveils Health Trust NFT to Empower Patient Data Control in Response to Regeneron's $600 Million 23andMe Bid | FRANKLIN, NJ / ACCESS Newswire / June 16, 2025 / Silver Scott Mines, Inc. (OTC PINK:SILS), a diversified digital technology company focused on healthcare, blockchain, and real-world asset tokenization... ► Artikel lesen | ||
| KALVISTA PHARMACEUTICALS | 6 | 1 | +3,74 % | KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Announces FDA Will Not Meet PDUFA Goal Date for Sebetralstat NDA for Hereditary Angioedema Due to FDA Resource Constraints | FDA states heavy workload and limited resources prevent meeting PDUFA goal date of June 17 Agency indicates anticipated decision within four weeks KalVista Pharmaceuticals, Inc. (Nasdaq: KALV)... ► Artikel lesen | ||
| NEXTCURE | 5 | - | +50,64 % | NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6 | NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rightsPhase 1 clinical trial ongoing for SIM0505 in China; U.S. Phase 1 clinical trial is expected... ► Artikel lesen | ||
| EVOTEC | 4 | 44 | -0,03 % | Aktie vor Turnaround?: Keine Geduld mehr mit Bayer und Evotec? Diese Aktie könnte die Lösung sein! | © Foto: Wolfgang Filser - picture alliance / SZ PhotoTurnaround-Wetten kosten viel Zeit, Nerven - und oft auch Geld. Vor allem Evotec und Bayer enttäuschten zuletzt immer wieder. Deutlich aussichtsreicher... ► Artikel lesen | ||
| REGENERON PHARMACEUTICALS | 4 | 22 | -0,13 % | Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer | |||
| BIONTECH | 4 | 13 | +0,11 % | BioNTech, Moderna und Co im Fokus: Kennedy greift durch | Nächster Paukenschlag in den USA: Gesundheitsminister Robert F. Kennedy Jr. hat alle Mitglieder eines Gremiums (ACIP) von Impfexperten der US- Seuchenbehörde CDC entlassen. Das geht aus einer Mitteilung... ► Artikel lesen | ||
| CSL | 4 | 7 | +0,25 % | Lunch Wrap: Trump's Tehran warning jolts oil stocks, CSL climbs on FDA nod |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 0,950 | 3,40 | +258 % | 1 | - | - | |||
| MARINOMED BIOTECH AG | 17,100 | 42 | +146 % | 2 | - | - | |||
| EVOTEC SE | 7,118 | 10,33 | +45 % | 7 | 2 | - | |||
| BIONTECH SE ADR | 92,10 | 118,94 | +29 % | 14 | 1 | - | |||
| QIAGEN NV | 40,775 | 48 | +18 % | 7 | 3 | - | |||
| SARTORIUS STEDIM BIOTECH SA | 201,70 | 235,80 | +17 % | 4 | 2 | - | |||
| CUREVAC NV | 4,704 | 4,34 | -8 % | - | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .